MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-12-2026
GBS Operating Income 2011-2026 | GBS
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income GBS
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.6 M | -10.3 M | -12.6 M | -8.34 M | -5.57 M | -2.86 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.86 M | -12.6 M | -8.38 M |
Quarterly Operating Income GBS
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.64 M | -3 M | - | -2.55 M | -2.26 M | -2.73 M | - | -2.95 M | -1.99 M | -2.53 M | - | -6.54 M | -2.13 M | - | -3.35 M | -1.34 M | -3.47 M | -1.44 M | -4.91 M | -3.14 M | -917 K | -663 K | -917 K | -28.8 K | -1.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -28.8 K | -6.54 M | -2.44 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Butterfly Network
BFLY
|
-74.4 M | $ 4.19 | 5.67 % | $ 887 M |  USA |
 |
InMode Ltd.
INMD
|
85.4 M | $ 13.73 | 1.48 % | $ 887 M |  Israel |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 34.86 | 4.68 % | $ 5.19 K | USA |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 9.51 | 5.32 % | $ 269 M | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
-82.1 M | $ 12.15 | -1.78 % | $ 1.82 B | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 9.1 | 0.33 % | $ 326 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
-7.85 M | $ 31.75 | 3.15 % | $ 1.46 B | USA |
 |
Establishment Labs Holdings
ESTA
|
-39 M | $ 59.61 | -4.85 % | $ 1.77 B |  Costa-rica |
 |
CONMED Corporation
CNMD
|
103 M | $ 36.63 | 1.92 % | $ 1.14 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 82.02 | -0.58 % | $ 48 B | USA |
 |
Electromed
ELMD
|
9.66 M | $ 24.49 | 5.2 % | $ 207 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
-16.8 M | $ 0.67 | 2.06 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
-9.34 M | $ 2.3 | 6.48 % | $ 3.59 M | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 2.06 | 0.98 % | $ 1.25 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
28.4 M | $ 9.43 | 5.48 % | $ 726 M | USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 10.37 | 4.64 % | $ 1.4 B | USA |
 |
IRIDEX Corporation
IRIX
|
-10 M | $ 1.35 | - | $ 21.8 M | USA |
 |
IRadimed Corporation
IRMD
|
26.1 M | $ 99.2 | -0.3 % | $ 1.26 B | USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.34 | -0.22 % | $ 120 M | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.73 | 3.32 % | $ 139 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 16.47 | -0.3 % | $ 386 M | USA |
 |
Inspire Medical Systems
INSP
|
51 M | $ 52.16 | -2.9 % | $ 1.53 B | USA |
 |
LivaNova PLC
LIVN
|
199 M | $ 63.24 | 1.69 % | $ 3.45 B |  Britain |
 |
Medtronic PLC
MDT
|
5.96 B | $ 87.17 | 1.13 % | $ 112 B | USA |
 |
Pulmonx Corporation
LUNG
|
-53.7 M | $ 1.39 | 2.21 % | $ 56.6 M | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Myomo
MYO
|
-14.4 M | $ 0.71 | 0.08 % | $ 29.7 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |